Showing results (1-10 of 496) with videos related to
Sort By:
Pageof 50
NDT Plus|May 19, 2015
Medical management after parathyroid interventionMotoko Tanaka, Masafumi FukagawaClinical Calcium|June 6, 2006
[Bone and bone related biochemical examinations. Hormone and hormone related substances. Parathyroid hormone]Motoko Tanaka, Masafumi FukagawaClinical Calcium|January 8, 2008
[Basic and clinical aspects of calcimimetics. Treatment of secondary hyperparathyroidism in dialysis patients with calcimimetics]Motoko Tanaka, Masafumi FukagawaTherapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 17, 2018
Emerging Association Between Parathyroid Hormone and Anemia in Hemodialysis PatientsMotoko Tanaka, Hirotaka Komaba, Masafumi FukagawaInternal Medicine (Tokyo, Japan)|June 4, 2008
Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)Hirotaka Komaba, Motoko Tanaka, Masafumi FukagawaJournal of Bone and Mineral Metabolism|October 31, 2006
The kidney and bone metabolism: Nephrologists' point of viewMasafumi Fukagawa, Yasuhiro Hamada, Shohei Nakanishi, et al.Nephron. Clinical Practice|September 17, 2005
Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidismMotoko Tanaka, Kazuko Itoh, Kazunori Matsushita, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 15, 2005
Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelinesMotoko Tanaka, Kazuko Itoh, Kazunori Matsushita, et al.NDT Plus|May 19, 2015
Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidismMotoko Tanaka, Shohei Nakanishi, Hirotaka Komaba, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Effects of raloxifene on bone mineral metabolism in postmenopausal Japanese women on hemodialysisMotoko Tanaka, Kazuko Itoh, Kazunori Matsushita, et al.Pageof 50